Iyanu V. Olateju MD, MHA*, Dolly Ogwu MD, Adaugo Opiegbe MD, Matthew O. Owolabi MD, MHA, Odunayo S. Lawal MD, MHA


Coronavirus disease (COVID-19) is majorly regarded as a respiratory system disease; however, several studies have reported a high incidence of coagulopathy in COVID-19 patients. The pathophysiology of the disease and the ability to activate multiple coagulopathy cascades are seen through literature as the mechanism for thromboembolism. This review aimed to evaluate the risk of thromboembolic complications in COVID-19 patients and analyze the management approach. We conducted a literature search through PubMed and Embase with specific common and MeSH keywords. We elicited various articles from which 37 reports pertinent to the objectives of this review were included following the exclusion of duplicates, non-English language publications, and non-full text reports. This review revealed the presence of an association between COVID-19 and the incidence of thromboembolism, especially in critically ill COVID-19 patients. This association has been linked to numerous factors like race/ethnicity, immune response, exaggerated systemic inflammatory and coagulation response. There is a need for comprehensive research to explore the racial/geographical distribution of thromboembolic complications of COVID 19 and any underlying pre-existing conditions that may predispose COVID patients to thromboembolism. This will help expand the prophylactic guidelines to such patient categories and ultimately decrease hospitalization and mortality rates.

Keywords: COVID-19, Thromboembolism, Coagulopathy, Thrombosis.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2023 Issue has been successfully launched on 1 MAY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction